036220 — Osang Healthcare Co Income Statement
0.000.00%
- KR₩229bn
- KR₩117bn
- KR₩356bn
Annual income statement for Osang Healthcare Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2015 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 50,383 | 257,967 | 132,327 | 193,893 | 355,847 |
Cost of Revenue | |||||
Gross Profit | 19,700 | 190,362 | 47,617 | 98,033 | 221,108 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 50,841 | 97,249 | 139,411 | 144,629 | 213,029 |
Operating Profit | -457 | 160,718 | -7,084 | 49,264 | 142,818 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -7,289 | 155,356 | 38.1 | 51,840 | 152,435 |
Provision for Income Taxes | |||||
Net Income After Taxes | -8,407 | 124,996 | 1,473 | 40,661 | 116,665 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -8,407 | 124,996 | 1,460 | 40,647 | 116,436 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -8,407 | 124,996 | 1,460 | 40,647 | 116,436 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1,063 | 9,188 | 107 | 2,977 | 8,652 |
Dividends per Share |